Back
Salesforce Vs. Regencell Bioscience Holdings Industry Stock Comparison
Buy
52
CRM
Salesforce
Last Price:
$269.89
Seasonality Move:
10.07%
Sell
27
RGC
Regencell Bioscience Holdings
Last Price:
$15.00
Seasonality Move:
23.7%
Buy
52
Salesforce (CRM)
is a Buy
Is Salesforce a Buy, Sell or Hold?
-
The current Salesforce [CRM] share price is $267.70. The Score for CRM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $15.18. The Score for RGC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $267.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing slight buying pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $15.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.9 | Sell |
Relative Strength Index (14 RSI): | 52.92 | Buy |
Chaikin Money Flow: | 738647 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (260.5 - 271.28) | Buy |
Bollinger Bands (100): | (257.56 - 282.56) | Sell |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.64 | Buy |
Relative Strength Index (14 RSI): | 46.65 | Sell |
Chaikin Money Flow: | 278856 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.22 - 29.96) | Sell |
Bollinger Bands (100): | (-2.63 - 23.31) | Buy |
CRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 262.32 | Buy |
20-day SMA: | 266.24 | Buy |
50-day SMA: | 269.97 | Sell |
200-day SMA: | 296.49 | Sell |
8-day EMA: | 264.38 | Buy |
20-day EMA: | 264.98 | Buy |
50-day EMA: | 258.72 | Buy |
200-day EMA: | 155.66 | Buy |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.55 | Buy |
20-day SMA: | 16.01 | Sell |
50-day SMA: | 19.24 | Sell |
200-day SMA: | 5.24 | Buy |
8-day EMA: | 14.2 | Buy |
20-day EMA: | 10.91 | Buy |
50-day EMA: | 6.15 | Buy |
200-day EMA: | 1.86 | Buy |
Salesforce Earnings Growth & CRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Salesforce Technical Analysis
Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |